Oppenheimer Initiates Coverage On Lindblad Expeditions with Outperform Rating, Announces Price Target of $25 - Lindblad Expeditions (NASDAQ:LIND)
Published on March 16, 2026.
The article discusses the possibility of a lawsuit against the company, alleging that it is not representative of the United Nations. The article also mentions the potential for a lawsuit alleging that the company is seeking to prevent future discrimination in relation to other businesses. The company's response to the allegations of sexual violence has been positively received by both parties involved.
Related Articles
Glencore turns to China exchange stocks to meet cobalt commitments, sources say
Glencore uses Wuxi exchange stocks to meet cobalt commitments due to limited supplies in Congo, which have led to significant price increases.
Elicio Therapeutics Launches $100M At-The-Market Offering Program, Replaces Prior $40M Sales Agreement - Elicio Therapeutics (NASDAQ:ELTX)
Elicio Therapeutics launched a $100m at-the-spot offering with immediate effect, replacing a previous deal with Southeastern European Union (EU) officials with a similar offer.
Structure Therapeutics Stock Explodes As Much-Awaited Experimental Oral Drug Trial Shows Weight Loss Of 16% - Structure Therapeutics (NASDAQ:GPCR)
Structure Therapeutics' stock rose 7.94% as positive weight loss results from its investigational oral drug aleniglipron boosted its market value, despite ongoing selling pressure and oversold stock.